Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COSTI: COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty - A Triple Blinded, Randomized Controlled Trial Pilot Study

NCT06809998 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT06809998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06809998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COSTI: COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty - A Triple Blinded, Randomized Controlled Trial Pilot Study
Lead sponsor
Unity Health Toronto
Phase
Phase 1/2
Overall status
Recruiting
Start date
January 24, 2025
Completion date
August 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bilateral knee osteoarthritis, osteoarthritis (oa) of the knee, osteoarthritis(primary), total knee anthroplasty